Your browser doesn't support javascript.
loading
Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
Patel, Yuval A; Yao, Jia; Proeschold-Bell, Rae Jean; Niedzwiecki, Donna; Goacher, Elizabeth; Muir, Andrew J.
Afiliação
  • Patel YA; Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC, USA. yuval.patel@duke.edu.
  • Yao J; Duke Center for Health Policy and Inequalities Research, Duke University, Durham, NC, USA.
  • Proeschold-Bell RJ; Duke Center for Health Policy and Inequalities Research, Duke University, Durham, NC, USA.
  • Niedzwiecki D; Duke Global Health Institute, Duke University, Durham, NC, USA.
  • Goacher E; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
  • Muir AJ; Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC, USA. elizabeth.goacher@duke.edu.
Dig Dis Sci ; 66(9): 2956-2963, 2021 09.
Article em En | MEDLINE | ID: mdl-32968965
BACKGROUND: Patients with chronic hepatitis C and risky/harmful alcohol use experience poor outcomes. Granular data evaluating whether alcohol counseling during hepatitis C treatment impacts longitudinal alcohol consumption are lacking. AIMS: To evaluate whether provider-delivered counseling in the context of direct-acting antiviral hepatitis C treatment associates with decreased longitudinal alcohol consumption. METHODS: We performed secondary data analysis from the Hep ART study including adults with hepatitis C who underwent provider-delivered counseling during direct-acting antiviral treatment between October 2014 and September 2017. Demographics and disease characteristics were summarized. Alcohol consumption, abstinence, and heavy drinking were evaluated in periods before, during, and after direct-acting antiviral treatment. Multivariate regression analyses were performed to evaluate the association of alcohol consumption with each 12-week time period for all patients and a subsample with cirrhosis. RESULTS: One hundred twenty-three patients were included; 41 had cirrhosis. Most patients were male (74.0%) and Black (58.5%). Alcohol consumption improved during direct-acting antiviral treatment and was notably sustained (< 12 weeks before treatment 32.5 g/day; during treatment 20.0 g/day; and 12-24 weeks after treatment 23.7 g/day). Multivariable analyses showed significantly improved alcohol consumption metrics during and after antiviral treatment compared to < 12 weeks before treatment (during treatment 13.04 g/day less, p = 0.0001; > 24 weeks after treatment 15.29 g/day less, p = 0.0001). The subsample with cirrhosis showed similar results (during treatment 13.21 g/day less, p = 0.0001; > 24 weeks after treatment 7.69 g/day less, p = 0.0001). CONCLUSIONS: Patients with chronic HCV and risky/harmful alcohol use given provider-delivered alcohol-related counseling during HCV treatment sustain decreased alcohol consumption patterns during and after treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Consumo de Bebidas Alcoólicas / Terapia Cognitivo-Comportamental / Hepatite C Crônica / Alcoolismo / Cirrose Hepática Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Consumo de Bebidas Alcoólicas / Terapia Cognitivo-Comportamental / Hepatite C Crônica / Alcoolismo / Cirrose Hepática Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021